Squarepoint Ops LLC Takes Position in Fresenius Medical Care AG (NYSE:FMS)

Squarepoint Ops LLC acquired a new position in shares of Fresenius Medical Care AG (NYSE:FMS - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 12,823 shares of the company's stock, valued at approximately $290,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of FMS. Yousif Capital Management LLC acquired a new position in Fresenius Medical Care during the fourth quarter worth $208,000. Autumn Glory Partners LLC acquired a new position in Fresenius Medical Care during the fourth quarter worth $208,000. ABC Arbitrage SA acquired a new position in Fresenius Medical Care during the fourth quarter worth $4,215,000. Sanctuary Advisors LLC acquired a new position in Fresenius Medical Care during the fourth quarter worth $983,000. Finally, Venturi Wealth Management LLC raised its holdings in Fresenius Medical Care by 8.4% during the fourth quarter. Venturi Wealth Management LLC now owns 5,700 shares of the company's stock worth $129,000 after purchasing an additional 441 shares during the last quarter. 8.37% of the stock is owned by institutional investors and hedge funds.

Fresenius Medical Care Trading Up 0.0%

Shares of FMS stock traded up $0.01 during trading hours on Tuesday, hitting $28.64. 472,968 shares of the company were exchanged, compared to its average volume of 334,776. The company has a quick ratio of 1.02, a current ratio of 1.37 and a debt-to-equity ratio of 0.42. The firm has a market cap of $16.81 billion, a PE ratio of 23.67, a PEG ratio of 0.76 and a beta of 0.88. Fresenius Medical Care AG has a 1 year low of $17.93 and a 1 year high of $30.46. The firm has a fifty day moving average of $26.49 and a 200 day moving average of $24.61.

Fresenius Medical Care (NYSE:FMS - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.44 EPS for the quarter, topping analysts' consensus estimates of $0.43 by $0.01. The business had revenue of $5.54 billion during the quarter, compared to the consensus estimate of $4.71 billion. Fresenius Medical Care had a return on equity of 6.04% and a net margin of 3.43%. Analysts expect that Fresenius Medical Care AG will post 1.51 earnings per share for the current year.

Fresenius Medical Care Increases Dividend

The firm also recently announced an annual dividend, which was paid on Friday, June 6th. Investors of record on Friday, May 23rd were issued a dividend of $0.7871 per share. This is a positive change from Fresenius Medical Care's previous annual dividend of $0.44. The ex-dividend date of this dividend was Friday, May 23rd. This represents a dividend yield of 1.9%. Fresenius Medical Care's payout ratio is presently 50.89%.

Analyst Ratings Changes

FMS has been the subject of several research reports. Truist Financial lifted their price objective on Fresenius Medical Care from $25.00 to $30.00 and gave the stock a "hold" rating in a report on Monday, May 12th. Wall Street Zen started coverage on Fresenius Medical Care in a report on Tuesday, May 20th. They set a "strong-buy" rating for the company. Finally, Morgan Stanley reissued an "underweight" rating on shares of Fresenius Medical Care in a report on Thursday, May 15th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, one has given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $27.80.

Fresenius Medical Care Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.